1952.HKEarnings•prnewswire•August 28, 2025 at 11:44 PM

Everest Medicines Announces Interim Results for First Half of 2025

Sentiment:Negative (20)

Summary

(1952.HK) SHANGHAI, Aug. 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 28, 2025 by prnewswire